Chan Zuckerberg Initiative (CZI) - Patient-Partnered Collaborations for Single-Cell Analysis of Rare Inflammatory Pediatric Disease RFA

CZI invites applications from collaborative teams bringing together patient-led rare disease organizations and research teams for 4-year research projects aimed at advancing our understanding of the fundamental science of rare diseases.

This RFA is intended to support early stage research on rare pediatric inflammatory diseases with sparse scientific research to date. It is not intended to further already mature areas of rare disease research, such as those supported by large organizations with extensive research programs or areas funded by governmental funding (e.g., NIH or the equivalent). We will prioritize support for patient organizations with annual research budgets less than $5 million.

The award period is for an initial two years of funding, followed by an additional two years, pending evaluation. CZI anticipates awarding $500,000 per year for a total of $2,000,000 for 48 months. Research teams will be awarded $400,000 per year for a total of $1,600,000. Patient organizations will receive $100,000 per year for a total of $400,000. This will be awarded separately and directly to the patient organization.

For more information, potential applicants are encouraged to attend an informational webinar on Wednesday, February 16 from 9 – 10:30 a.m.